How UCB built engagement on Facebook
Stephen WhitesideWarc
People with epilepsy often welcome the support of their fellow sufferers and actively embrace the chance to learn about their condition. The challenge for UCB – the maker of Vimpat and Keppra XR, two drugs assisting in the treatment of partial-onset seizures – was finding a way to help them do so while staying inside the pharma sector's strict regulations.
An online listening exercise conducted by UCB just over 18 months ago, when Trish Nettleship joined as its director/social media and influence, emphasised just how crucial it was to meet these...